BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dakroub A, A Nasser S, Younis N, Bhagani H, Al-Dhaheri Y, Pintus G, Eid AA, El-Yazbi AF, Eid AH. Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders. Cells 2020;9:E2444. [PMID: 33182523 DOI: 10.3390/cells9112444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yaribeygi H, Maleki M, Atkin SL, Jamialahmadi T, Sahebkar A. Impact of Incretin-Based Therapies on Adipokines and Adiponectin. J Diabetes Res 2021;2021:3331865. [PMID: 34660808 DOI: 10.1155/2021/3331865] [Reference Citation Analysis]
2 Ghanem MS, Monacelli F, Nencioni A. Advances in NAD-Lowering Agents for Cancer Treatment. Nutrients 2021;13:1665. [PMID: 34068917 DOI: 10.3390/nu13051665] [Reference Citation Analysis]
3 Dakroub A, Nasser SA, Kobeissy F, Yassine HM, Orekhov A, Sharifi-Rad J, Iratni R, El-Yazbi AF, Eid AH. Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases. J Cell Physiol 2021;236:6282-96. [PMID: 33634486 DOI: 10.1002/jcp.30345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Łukawska-Tatarczuk M, Franek E, Czupryniak L, Joniec-Maciejak I, Pawlak A, Wojnar E, Zieliński J, Mirowska-Guzel D, Mrozikiewicz-Rakowska B. Sirtuin 1, Visfatin and IL-27 Serum Levels of Type 1 Diabetic Females in Relation to Cardiovascular Parameters and Autoimmune Thyroid Disease. Biomolecules 2021;11:1110. [PMID: 34439776 DOI: 10.3390/biom11081110] [Reference Citation Analysis]
5 Hung SY, Lin CY, Yu CC, Chen HT, Lien MY, Huang YW, Fong YC, Liu JF, Wang SW, Chen WC, Tang CH. Visfatin Promotes the Metastatic Potential of Chondrosarcoma Cells by Stimulating AP-1-Dependent MMP-2 Production in the MAPK Pathway. Int J Mol Sci 2021;22:8642. [PMID: 34445345 DOI: 10.3390/ijms22168642] [Reference Citation Analysis]
6 Akcabag E, Bayram Z, Kucukcetin IO, Uzun G, Ozdem S, Ozdem SS. Functional effects of visfatin in isolated rat mesenteric small resistance arteries. Eur J Pharmacol 2021;908:174333. [PMID: 34280396 DOI: 10.1016/j.ejphar.2021.174333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Susairaj P, Snehalatha C, Nanditha A, Satheesh K, Raghavan A, Vinitha R, Ramachandran A. Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes. Sci Rep 2021;11:20327. [PMID: 34645898 DOI: 10.1038/s41598-021-99784-x] [Reference Citation Analysis]
8 Heo YJ, Choi SE, Lee N, Jeon JY, Han SJ, Kim DJ, Kang Y, Lee KW, Kim HJ. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model. J Gastroenterol Hepatol 2021. [PMID: 33600604 DOI: 10.1111/jgh.15465] [Cited by in F6Publishing: 1] [Reference Citation Analysis]